ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the ...
Stereotaxis was forced to do a human trial for its Magic catheter before it can get CE Mark. This is starting in a few weeks. Stereotaxis will soon submit a PMA for FDA approval of the Magic catheter ...
Stereotaxis has announced the publication of initial clinical results for its MAGiC catheter in the Journal of Interventional Cardiac Electrophysiology, marking the first peer-reviewed support for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback